A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 Diabetes
NCT00400283
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes
Diabetes Mellitus, Type 2
Interventions
DRUG:
NNC 55-0414
Sponsor
Novo Nordisk A/S